Skeletal dysplasias and the growth plate

Clinical Genetics

Volumn 73, Issue 1, 2008, Pages 24-30

  Alman, Benjamin A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 9; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ACHONDROPLASIA; ARTICLE; BONE DEVELOPMENT; BONE DYSPLASIA; CARTILAGE CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; ENCHONDROMATOSIS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HYPOCHONDROPLASIA; MESENCHYME CELL; NONHUMAN; OSSIFICATION; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPONDYLOEPIPHYSEAL DYSPLASIA; THANATOPHORIC DWARFISM;

BONE DISEASES, DEVELOPMENTAL; CHONDROCYTES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REGULATOR; GROWTH PLATE; HUMANS;

EID: 37249001756     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00933.x     Document Type: Article

References (33)

1. Lachman RS. International nomenclature and classification of the osteochondrodysplasias (1997). Pediatr Radiol 1998: 28 (10): 737-744.
2. Ikegawa S. Genetic analysis of skeletal dysplasia: Recent advances and perspectives in the post-genome-sequence era. J Hum Genet 2006: 51 (7): 581-586.
3. Hopyan S, Gokgoz N, Poon R et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002: 30 (3): 306-310.
4. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003: 423 (6937): 332-336.
5. Ng JK, Tamura K, Buscher D, Izpisua-Belmonte JC. Molecular and cellular basis of pattern formation during vertebrate limb development. Curr Top Dev Biol 1999: 41: 37-66.
6. Tickle C. Molecular basis of vertebrate limb patterning. Am J Med Genet 2002: 112 (3): 250-255.
7. Cohen MM Jr. The new bone biology: Pathologic, molecular, and clinical correlates. Am J Med Genet A 2006: 140 (23): 2646-2706.
8. Kronenberg HM. PTHrP and skeletal development. Ann N Y Acad Sci 2006: 1068: 1-13.
9. Magne D, Julien M, Vinatier C, Merhi-Soussi F, Weiss P, Guicheux J. Cartilage formation in growth plate and arteries: From physiology to pathology. Bioessays 2005: 27 (7): 708-716.
10. Alman BA. A classification for genetic disorders of interest to orthopaedists. Clin Orthop Relat Res 2002: 401: 17-26.
11. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 2000: 19 (5): 389-394.
12. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005: 75 (3): 200-212.
13. Tchetina E, Mwale F, Poole AR. Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J Bone Miner Res 2003: 18 (5): 844-851.
14. Lanske B, Karaplis AC, Lee K et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996: 273 (5275): 663-666.
15. Maddox BK, Garofalo S, Smith C, Keene DR, Horton WA. Skeletal development in transgenic mice expressing a mutation at Gly574Ser of type II collagen. Dev Dyn 1997: 208 (2): 170-177.
16. Garofalo S, Vuorio E, Metsaranta M et al. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A 1991: 88 (21): 9648-9652.
17. So CL, Kaluarachchi K, Tam PP, Cheah KS. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthritis Cartilage 2001: 9 (Suppl. A): S160-S173.
18. Czarny-Ratajczak M, Lohiniva J, Rogala P et al. A mutation in COL9A1 causes multiple epiphyseal dysplasia: Further evidence for locus heterogeneity. Am J Hum Genet 2001: 69 (5): 969-980.
19. Eyre DR, Apon S, Wu JJ, Ericsson LH, Walsh KA. Collagen type IX: evidence for covalent linkages to type II collagen in cartilage. FEBS Lett 1987: 220 (2): 337-341.
20. Foster JW, Dominguez-Steglich MA, Guioli S et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994: 372 (6506): 525-530.
21. Houston CS, Opitz JM, Spranger JW et al. The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971. Am J Med Genet 1983: 15 (1): 3-28.
22. Shiang R, Thompson LM, Zhu YZ et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994: 78 (2): 335-342.
23. Maroteaux P, Lamy M. Achondroplasia in man and animals. Clin Orthop Relat Res 1964: 33: 91-103.
24. Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI Jr. Medical complications of achondroplasia: A multicentre patient review. J Med Genet 1998: 35 (9): 705-712.
25. Blomstrand S, Claesson I, Save-Soderbergh J. A case of lethal congenital dwarfism with accelerated skeletal maturation. Pediatr Radiol 1985: 15 (2): 141-143.
26. Gordon SL, Varano LA, Alandete A, Maisels MJ. Jansen's metaphyseal dysostosis. Pediatrics 1976: 58 (4): 556-560.
27. Jobert AS, Zhang P, Couvineau A et al. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 1998: 102 (1): 34-40.
28. Schipani E, Kruse K, Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995: 268 (5207): 98-100.
29. Mundlos S, Otto F, Mundlos C et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997: 89 (5): 773-779.
30. Hinoi E, Bialek P, Chen YT et al. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev 2006: 20 (21): 2937-2942.
31. Mundlos S. Cleidocranial dysplasia: Clinical and molecular genetics. J Med Genet 1999: 36 (3): 177-182.
32. Murray LW, Bautista J, James PL, Rimoin DL. Type II collagen defects in the chondrodysplasias. I. Spondyloepiphyseal dysplasias. Am J Hum Genet 1989: 45 (1): 5-15.
33. Spranger JW, Langer LO Jr. Spondyloepiphyseal dysplasia congenita. Radiology 1970: 94 (2): 313-322.